Target intelligence / Profile preview

PTPRJ antisense RNA 1 (PTPRJ-AS1)

Target
PTPRJ-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

PTPRJ antisense RNA 1 (PTPRJ-AS1) is a long non-coding RNA (lncRNA) transcribed in the antisense direction relative to the PTPRJ gene locus. It is highly expressed in macrophage-enriched tissues and is transiently induced by proinflammatory stimuli, such as Toll-like receptor ligands, with a similar expression pattern to PTPRJ itself[1]. There is evidence that such antisense lncRNAs can influence the expression or splicing of nearby genes, suggesting that PTPRJ-AS1 may have a regulatory role affecting the PTPRJ gene. However, the specific molecular function of PTPRJ-AS1 remains unknown, and there is no established direct therapeutic targeting of this RNA[1][5]. PTPRJ-AS1 is not a protein, receptor, enzyme, or classical drug target in its own right, but may play a role in gene regulation through its lncRNA activity[1][5]. The role in disease is likely indirect and mediated via regulation of PTPRJ, a receptor-type protein tyrosine phosphatase involved in cell signaling and tumor suppression[1]. Currently, there are no known drugs, biomarkers, mechanisms of action, or safety concerns associated specifically with PTPRJ-AS1.

Other names
PTPRJ-AS1PTPRJ Antisense RNA 1
02

Biological functions

May regulate PTPRJ gene expression or splicingCo-expressed with PTPRJ in macrophage-enriched tissuePotential regulator in inflammatory response
03

Disease associations

Other (possible, indirect role via regulation of PTPRJ, which is implicated in cancer and inflammatory disease)

Beyond the preview

Go deeper on PTPRJ antisense RNA 1 (PTPRJ-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PTPRJ antisense RNA 1 (PTPRJ-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call